Cardiovascular Disease and COVID-19 Vaccines: A Systematic Review and Analysis of Published Cases.

Autor:	Khaity A; Faculty of Medicine, Elrazi University Khartoum, Sudan., Rababah AAM; Department of Medicine, King Hussein Medical Center Amman, Jordan., Abdelwahab OA; Faculty of Medicine, Al-Azhar University Cairo, Egypt., Albakri K; Faculty of Medicine, Hashemite University Zarqa, Jordan., Diab RA; Faculty of Medicine, Al-Azhar University Cairo, Egypt., Al-Dardery NM; Faculty of Medicine, Fayoum University Fayoum, Egypt., Abbassy M; Department of Medicine, Royal College of Surgeons in Ireland Dublin, Ireland., Al-Hanaqtah BM; Faculty of Medicine, Hashemite University Zarqa, Jordan., Awad AK; Faculty of Medicine, Ain-Shams University Cairo, Egypt., Mohamad T; Department of Interventional Cardiology, Wayne State University School of Medicine, Detroit Medical Center Detroit, MI, US.
Jazyk:	angličtina
Zdroj:	European cardiology [Eur Cardiol] 2023 Sep 13; Vol. 18, pp. e54. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).
DOI:	10.15420/ecr.2023.01
Abstrakt:	As vaccination against COVID-19 became more widespread, side-effects that were not initially detected during clinical trials became more prominent. The aim of this systematic review is to discuss reports of adverse cardiovascular events associated with COVID-19 vaccination. Databases were searched from inception up to August 2022 to identify case reports and case series reporting on patients with cardiovascular disease after COVID-19 vaccination. This study assessed 150 published cases. Of these, 109 were case reports and 41 were case series. The majority of patients were male (n=302, 86.6%), with a mean age of 27.6 ± 16.7 years. Of the included patients, 268 (76.6%) had myocarditis, 50 (14.6%) had myopericarditis, 8 (2.3%) had pericarditis, and only 4 (1.1%) had stress-induced cardiomyopathy. Moreover, 30 (8.6%) and 11 (3.1%) were diagnosed with arrhythmia and ischaemic heart disease, respectively. Ultimately, cardiovascular complications after COVID-19 vaccination include myocarditis, myopericarditis, ischaemic heart disease and arrhythmia. The young population, especially young male patients, could be more vulnerable to myocarditis. Competing Interests: Disclosure: The authors have no conflicts of interest to declare. (Copyright © The Author(s), 2023. Published by Radcliffe Group Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu